Method for the treatment of neoplastic disease utilizing taxol and tiazofurin
CA 2129282 A1 · Owner: Indiana University Foundation · Inventors: Look, Katherine Y.; Weber, George
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating neoplastic cells using a combination of taxol and tiazofurin. Preferably, the taxol is administered in a dosage of approximately 110 mg/m2 to approximately 250 mg/m2 on a single day, followed by 31 days of rest and the tiazofurin is, administered in a dosage of approximately 1,800 to 4,400 mg/m2 over a period of about ten days, followed by 21 days of rest and, the taxol and tiazofurin administration cycles are in phase with each other.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 2, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 2, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 2, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.